Quick Summary — CLX scores higher on quality with 8.7/10 vs GROV's 4.1/10. CLX trades at $89.63 while GROV trades at $1.15. Both analyzed daily using SEC EDGAR data across 13 institutional models.
CLX scores higher with a 8.7/10 quality rating vs GROV's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
At $89.63, CLX trades +12.3% above its Bayesian DCF fair value of $78.58, while GROV at $1.15 trades +69.2% above its estimate of $0.36. GROV shows a wider gap between price and intrinsic value.
CLX earns a Quality of Company score of 8.7/10 compared to GROV's 4.1/10. This is a significant quality gap — the higher-scoring company demonstrates materially stronger fundamentals across profitability, growth consistency, and balance sheet health. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.
Review the value trap analysis for both CLX and GROV to assess whether apparent undervaluation reflects genuine opportunity or hidden fundamental risk.
Both CLX and GROV operate in Household & Personal Products, which has 30 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).
11 hidden models compare CLX vs GROV differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.
Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day
See All 13 Models — $0.90/dayWe don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.